Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot O43151: Variant p.Val1089Met

Methylcytosine dioxygenase TET3
Gene: TET3
Feedback?
Variant information Variant position: help 1089 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Valine (V) to Methionine (M) at position 1089 (V1089M, p.Val1089Met). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Similar physico-chemical property. Both residues are medium size and hydrophobic. The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In BEFAHRS; decreases methylcytosine dioxygenase activity. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 1089 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 1795 The length of the canonical sequence.
Location on the sequence: help CMDFCAHAHKDQHNLYNGCT V VCTLTKEDNRCVGKIPEDEQ The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         CMDFCAHAHKDQHNLYNGCTVVCTLTKEDNRCVGKIPEDEQ

Mouse                         CMDFCAHAHKDQHNLYNGCTVVCTLTKEDNRCVGQIPEDEQ

Xenopus tropicalis            CMDFCAHAHKDQHNLYNGCTVVCTLTKEDNRMIGRVAEDEQ
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 1795 Methylcytosine dioxygenase TET3
Binding site 1069 – 1069
Binding site 1075 – 1075
Binding site 1077 – 1077
Binding site 1079 – 1079
Binding site 1082 – 1082
Alternative sequence 863 – 1795 Missing. In isoform 3.



Literature citations
Delineation of a Human Mendelian Disorder of the DNA Demethylation Machinery: TET3 Deficiency.
Beck D.B.; Petracovici A.; He C.; Moore H.W.; Louie R.J.; Ansar M.; Douzgou S.; Sithambaram S.; Cottrell T.; Santos-Cortez R.L.P.; Prijoles E.J.; Bend R.; Keren B.; Mignot C.; Nougues M.C.; Ounap K.; Reimand T.; Pajusalu S.; Zahid M.; Saqib M.A.N.; Buratti J.; Seaby E.G.; McWalter K.; Telegrafi A.; Baldridge D.; Shinawi M.; Leal S.M.; Schaefer G.B.; Stevenson R.E.; Banka S.; Bonasio R.; Fahrner J.A.;
Am. J. Hum. Genet. 106:234-245(2020)
Cited for: INVOLVEMENT IN BEFAHRS; VARIANTS BEFAHRS CYS-752; MET-851; LEU-908; CYS-1072; THR-1076; MET-1089; LEU-1677 AND 1695-GLN--ILE-1795 DEL; CHARACTERIZATION OF VARIANTS BEFAHRS CYS-752; LEU-908; CYS-1072; THR-1076 AND MET-1089; FUNCTION; CATALYTIC ACTIVITY; MUTAGENESIS OF 1077-HIS--ASP-1079;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.